Abbott Laboratories (ABT) Revenue (2009 - 2026)

Abbott Laboratories has disclosed Revenue across 18 years of filings, most recently posting $11.2 billion for Q1 2026.

• Revenue for Q1 2026 came in at $11.2 billion, up 7.78% year-over-year; the trailing twelve-month figure through Mar 2026 was $45.1 billion (up 6.59% YoY), and the FY2025 annual result was $44.3 billion, up 5.67% from the prior year.
• Revenue came in at $11.2 billion for Q1 2026 at Abbott Laboratories, down from $11.5 billion in the prior quarter.
• In the past five years, Revenue ranged from a high of $11.9 billion in Q1 2022 to a low of $9.7 billion in Q1 2023.
• The 5-year median for Revenue is $10.4 billion (2022), against an average of $10.7 billion.
• Across the five-year window, Revenue advanced 13.76% in 2022 and declined 18.06% in 2023, its largest moves.
• Abbott Laboratories' Revenue stood at $10.1 billion in 2022, then increased by 1.49% to $10.2 billion in 2023, then gained by 7.16% to $11.0 billion in 2024, then increased by 4.42% to $11.5 billion in 2025, then retreated by 2.57% to $11.2 billion in 2026.
• The last three Revenue figures came in at $11.2 billion (Q1 2026), $11.5 billion (Q4 2025), and $11.4 billion (Q3 2025), per Business Quant data.